Literature DB >> 12973639

Importation and circulation of poliovirus in Bulgaria in 2001.

Mira Kojouharova1, Patrick L F Zuber, Snejana Gyurova, Lucia Fiore, Gabriele Buttinelli, Angel Kunchev, Nadejda Vladimirova, Neli Korsun, Radosveta Filipova, Roumiana Boneva, Eugene Gavrilin, Jagadish M Deshpande, George Oblapenko, Steven G Wassilak.   

Abstract

OBJECTIVE: To characterize the circumstances in which poliomyelitis occurred among three children in Bulgaria during 2001 and to describe the public health response.
METHODS: Bulgarian authorities investigated the three cases of polio and their contacts, conducted faecal and serological screening of children from high-risk groups, implemented enhanced surveillance for acute flaccid paralysis, and conducted supplemental immunization activities.
FINDINGS: The three cases of polio studied had not been vaccinated and lived in socioeconomically deprived areas of two cities. Four Roma children from the Bourgas district had antibody titres to serotype 1 poliovirus only, and wild type 1 virus was isolated from the faeces of two asymptomatic Roma children in the Bourgas and Sofia districts. Poliovirus isolates were related genetically and represented a single evolutionary lineage; genomic sequences were less than 90% identical to poliovirus strains isolated previously in Europe, but 98.3% similar to a strain isolated in India in 2000. No cases or wild virus isolates were found after supplemental immunization activities were launched in May 2001.
CONCLUSIONS: In Bulgaria, an imported poliovirus was able to circulate for two to five months among minority populations. Surveillance data strongly suggest that wild poliovirus circulation ceased shortly after supplemental immunization activities with oral poliovirus vaccine were conducted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12973639      PMCID: PMC2572497     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 2.  Revisiting the evidence on health and health care disparities among the Roma: a systematic review 2003-2012.

Authors:  Benjamin Cook; Geoffrey Ferris Wayne; Anne Valentine; Anna Lessios; Ethan Yeh
Journal:  Int J Public Health       Date:  2013-10-05       Impact factor: 3.380

3.  The interconnected and cross-border nature of risks posed by infectious diseases.

Authors:  Jonathan E Suk; Thomas Van Cangh; Julien Beauté; Cornelius Bartels; Svetla Tsolova; Anastasia Pharris; Massimo Ciotti; Jan C Semenza
Journal:  Glob Health Action       Date:  2014-10-10       Impact factor: 2.640

4.  Deconvolving mutational patterns of poliovirus outbreaks reveals its intrinsic fitness landscape.

Authors:  Ahmed A Quadeer; John P Barton; Arup K Chakraborty; Matthew R McKay
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

5.  Retrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece.

Authors:  Stefano Fontana; Gabriele Buttinelli; Stefano Fiore; Concetta Amato; Marco Pataracchia; Majlinda Kota; Jela Aćimović; Mia Blažević; Mirsada Mulaomerović; Lubomira Nikolaeva-Glomb; Andreas Mentis; Androniki Voulgari-Kokota; Luljeta Gashi; Pranvera Kaçaniku-Gunga; Christopher Barbara; Jackie Melillo; Jelena Protic; Svetlana Filipović-Vignjevic; Patrick M O'Connor; Alessandra D'Alberto; Riccardo Orioli; Andrea Siddu; Eugene Saxentoff; Paola Stefanelli
Journal:  Vaccines (Basel)       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.